Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Vaccine|January 1, 1992
Protection from herpes simplex virus type 2 is associated with T cells involved in delayed type hypersensitivity that recognize glycosylation-related epitopes on glycoprotein DM Wachsman, J H Luo, L Aurelian, et al.
The Journal of Infectious Diseases|September 1, 1985
Immunity to herpes simplex virus: virus reactivation modulates lymphokine activityJ F Sheridan, M Beck, L Aurelian, et al.
Japanese Journal of Cancer Research : Gann|October 1, 1985
The cervical tumor-associated antigen (ICP-10/AG-4) is encoded by the transforming region of the genome of herpes simplex virus type 2T Iwasaka, C Smith, L Aurelian, et al.
Journal of Virology|October 10, 1998
The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growthC C Smith, T Peng, M Kulka, et al.
Dermatology (Basel, Switzerland)|July 7, 1999
Longitudinal study of a patient with herpes-simplex-virus-associated erythema multiforme: viral gene expression and T cell repertoire usageH Kokuba, S Imafuku, J W Burnett, et al.
Vaccine|March 3, 2001
A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigsM Wachsman, M Kulka, C C Smith, et al.
Antisense & Nucleic Acid Drug Development|January 1, 1996
Herpes simplex virus-mediated activation of human immunodeficiency virus is inhibited by oligonucleoside methylphosphonates that target immediate-early mRNAs 1 and 3C P Feng, M Kulka, C Smith, et al.
Reviews of Infectious Diseases|November 1, 1991
Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein DL Aurelian, C C Smith, M Wachsman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitroJ F Sheridan, M Beck, C C Smith, et al.
Indian Journal of Experimental Biology|June 5, 1999
Prevalence of serum antibodies to LA-1 oncoprotein, herpes simplex virus type-2 glycoprotein and human papillomavirus type 16 transactivator (E2) protein among Indian women with cervical neoplasiaB K Sharma, R Sharma, C C Smith, et al.
Pageof 12